Low density lipoprotein aggregated by sphingomyelinase is internalised by macrophages and oxidised in lysosomes

      Background: Large trials of antioxidants to inhibit low density lipoprotein (LDL) oxidation have failed to protect against cardiovascular disease. We have shown that LDL aggregated by vortexing is internalised by macrophages and oxidised by iron in lysosomes. This raises the novel possibility that antioxidants targetting lysosomes might be a therapy for atherosclerosis.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect